Deletion of Gpatch2 does not alter Tnf expression in mice

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Tumor necrosis factor (TNF) is crucial for immune defense but its dysregulation causes inflammatory diseases.
• Controlling TNF levels is vital for immune homeostasis and overall health.
• GPATCH2 was identified as a potential post-transcriptional repressor of TNF via its 3' UTR.

Purpose of the Study:

• To investigate the in vivo role of GPATCH2 in regulating TNF expression.
• To characterize the phenotype of Gpatch2 knockout mice.

Main Methods:

• CRISPR screening to identify TNF regulators.
• Generation and analysis of Gpatch2 knockout (Gpatch2-/-) mice on a C57BL/6 background.
• Assessment of basal and inflammation-induced TNF expression (LPS and SMAC-mimetic models).
• Histological examination of tissues and blood cell composition analysis.

Main Results:

• GPATCH2 protein was detected in mouse testis and other tissues.
• Gpatch2-/- mice exhibited normal basal and inflammation-induced TNF expression.
• No significant morphological abnormalities were observed in Gpatch2-/- mice, including lymphoid tissues.
• Gpatch2-/- mice were viable and grossly normal with no notable aberrations in blood cell counts.

Conclusions:

• GPATCH2 does not appear to play a discernible role in regulating TNF expression in vivo.
• The absence of an overt phenotype in Gpatch2-/- mice suggests further investigation is needed to elucidate GPATCH2's function.
• The proposed role of GPATCH2 as a TNF repressor requires re-evaluation based on these findings.